Influence of atorvastatin on levels of hsCRP, IL-6 and TNF-α in patients with acute coronary syndrome
10.3969/j.issn.1008-0074.2017.02.30
- VernacularTitle:阿托伐他汀对急性冠脉综合征患者hsCRP、IL-6、TNF-α水平的影响
- Author:
Anping GUAN
;
Kun XING
- Keywords:
Acute coronary syndrome;
C-reactive protein;
Atorvastatin
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2017;26(2):222-224
- CountryChina
- Language:Chinese
-
Abstract:
Many researches proved that inflammation plays a decisive role in occurrence, development and prognosis of acute coronary syndrome (ACS).Atorvastatin possesses many other effects besides lipid regulation, and anti-inflammatory effect is the most significant one.Some studies indicated that atorvastatin can reduce levels of high sensitive C reactive protein (hsCRP), interleukin (IL)-6 and tumor necrosis factor (TNF)-α in ACS patients, then inhibit postoperative inflammation, improve postoperative blood flow perfusion and reduce occurrence of acute coronary events.The present article made a review on influence of atorvastatin on levels of hsCRP, IL-6 and TNF-α in ACS patients.
